Humira, Abilify, Top Selling Drugs

Article archive / September 1, 2015

Originally published: . Volume 6, No. 9. Source pages: 10.

According to IMS Health the top selling drug is Humir, an arthritis drug with sales of about $8.6 billion, followed by the antipsychotic aripiprazole, Abilify, at $7.2 billion. The arthritis drug Enbrel was next at $6.1 billion.


This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.